Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Giorgio L Colombo"'
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol 2011, Iss default, Pp 55-61 (2011)
Giorgio L Colombo1,2, Sergio Di Matteo2, Maria Elisa Mancuso3, Elena Santagostino31University of Pavia, School of Pharmacy, Pavia, Italy; 2S.A.V.E. Studi Analisi Valutazioni Economiche, Milan, Italy; 3Angelo Bianchi Bonomi Hemophilia and Thrombosis C
Externí odkaz:
https://doaj.org/article/b7bc2821644341ed9d37ea9f258a3393
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol 2011, Iss default, Pp 37-46 (2011)
Giorgio L Colombo1,2, Giovanni B Gaeta3, Mauro Viganò4, Sergio Di Matteo21University of Pavia, School of Pharmacy, Italy; 2S.A.V.E. Studi Analisi Valutazioni Economiche, Milan, Italy; 3Viral Hepatitis Unit, Second University, Naples, Italy; 4Liver U
Externí odkaz:
https://doaj.org/article/f50f01f59f9e48b3906eedc43cd9d5e4
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol 2009, Iss default, Pp 53-59 (2009)
Giorgio L Colombo1, Sergio Di Matteo2, Ketty Peris3, Maria Concetta Fargnoli3, Maria Esposito4, Annamaria Mazzotta4, Sergio Chimenti41Faculty of Pharmacy, University of Pavia, Pavia, Italy; 2S.A.V.E. Studi Analisi Valutazioni Economiche, Milan, Italy
Externí odkaz:
https://doaj.org/article/f958c8ccfc514b52b6226a95d3c49d65
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol 2008, Iss Issue 5, Pp 967-976 (2008)
Giorgio L Colombo1, Mauro Caruggi2, Sergio Di Matteo1, Alessandro Rossi31S.A.V.E. Studi Analisi Valutazioni Economiche, Milano, Italy; 2Università degli Studi dell’Insubria, Varese, Italy; 3Università de L’Aquila, ItalyObjective: To evaluate th
Externí odkaz:
https://doaj.org/article/fa941aaa404341eea6ececf0ad777659
Publikováno v:
Vascular Health and Risk Management, Vol Volume 4, Pp 223-234 (2008)
Giorgio L Colombo1, Mauro Caruggi2, Chiara Ottolini3, Aldo P Maggioni41S.A.V.E. Studi Analisi Valutazioni Economiche, Milano, Italy; 2Università degli Studi dell’Insubria, Varese, Italy;3Azienda Ospedaliera di Busto Arsizio, Varese, Italy; 4ANMCO
Externí odkaz:
https://doaj.org/article/be48a348db4b42f5a3e2f4f31ab7fd58
Autor:
Giorgio L Colombo, Enrico Agabiti-Rosei, Alberto Margonato, Claudio Mencacci, Carlo Maurizio Montecucco, Roberto Trevisan
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e82990 (2013)
The scientific documentation supporting the potential clinical and economic benefits of a growing use of off-patent generic drugs in clinical practice seems to be limited in Italy as yet.We compared differences in outcomes between off-patent generic
Externí odkaz:
https://doaj.org/article/7f5abf4ff78f457881ff89c687f7d3e7
Autor:
Chantal M. Morel, Richard A. Alm, Christine Årdal, Alessandra Bandera, Giacomo M. Bruno, Elena Carrara, Giorgio L. Colombo, Marlieke E. A. de Kraker, Sabiha Essack, Isabel Frost, Bruno Gonzalez-Zorn, Herman Goossens, Luca Guardabassi, Stephan Harbarth, Peter S. Jørgensen, Souha S. Kanj, Tomislav Kostyanev, Ramanan Laxminarayan, Finola Leonard, Gabriel Levy Hara, Marc Mendelson, Malgorzata Mikulska, Nico T. Mutters, Kevin Outterson, Jesus Rodriguez Baňo, Evelina Tacconelli, Luigia Scudeller, the GAP-ON€ network
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 9, Iss 1, Pp 1-14 (2020)
Abstract Objectives/purpose The costs attributable to antimicrobial resistance (AMR) remain theoretical and largely unspecified. Current figures fail to capture the full health and economic burden caused by AMR across human, animal, and environmental
Externí odkaz:
https://doaj.org/article/dc4a2198b87d4b42aacdc8e28e00a7d0
Autor:
Giacomo M Bruno, Maria Chiara Valentino, Alessandra Brunetti, Sergio Di Matteo, Ivan Begovic, Edoardo Croce, Garifallia Sakellariou, Serena Bugatti, Pietro Perotti, Silvia Vecchio, Simona Migliazza, Roberto Langella, Giorgio L Colombo
Publikováno v:
Pragmatic and Observational Research. 14:29-38
Giacomo M Bruno,1,2 Maria Chiara Valentino,2 Alessandra Brunetti,3 Sergio Di Matteo,2 Ivan Begovic,2 Edoardo Croce,4 Garifallia Sakellariou,5 Serena Bugatti,6 Pietro Perotti,7 Silvia Vecchio,7 Simona Migliazza,7 Roberto Langella,8 Giorgio L Colombo1,
Autor:
Andrea Rasola, Alice Triveri, Stefano A. Serapian, Francesco Frigerio, Elisabetta Moroni, Filippo Doria, Fabrizio Cinquini, Giorgio L Colombo, Silvia Pavoni, Filippo Marchetti
Publikováno v:
Journal of Chemical Information and Modeling
Journal of chemical information and modeling (2021). doi:10.1021/acs.jcim.1c00857
info:cnr-pdr/source/autori:Triveri A.; Serapian S.A.; Marchetti F.; Doria F.; Pavoni S.; Cinquini F.; Moroni E.; Rasola A.; Frigerio F.; Colombo G./titolo:SARS-CoV-2 Spike Protein Mutations and Escape from Antibodies: A Computational Model of Epitope Loss in Variants of Concern/doi:10.1021%2Facs.jcim.1c00857/rivista:Journal of chemical information and modeling/anno:2021/pagina_da:/pagina_a:/intervallo_pagine:/volume
Journal of chemical information and modeling (2021). doi:10.1021/acs.jcim.1c00857
info:cnr-pdr/source/autori:Triveri A.; Serapian S.A.; Marchetti F.; Doria F.; Pavoni S.; Cinquini F.; Moroni E.; Rasola A.; Frigerio F.; Colombo G./titolo:SARS-CoV-2 Spike Protein Mutations and Escape from Antibodies: A Computational Model of Epitope Loss in Variants of Concern/doi:10.1021%2Facs.jcim.1c00857/rivista:Journal of chemical information and modeling/anno:2021/pagina_da:/pagina_a:/intervallo_pagine:/volume
The SARS-CoV-2 spike (S) protein is exposed on the viral surface and is the first point of contact between the virus and the host. For these reasons it represents the prime target for Covid-19 vaccines. In recent months, variants of this protein have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b5c206718be83e4ccb612b8bb6e8c10
https://doi.org/10.1101/2021.07.12.452002
https://doi.org/10.1101/2021.07.12.452002
Autor:
Giorgio L. Colombo, Andrea Muzio
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 4, Iss 1, Pp 17-24 (2003)
The clinical management of acid-related diseases incurs the consumption of a relevant part of the health resources in Italy, as indicated by the fact that PPIs (proton pump inhibitors) represented the first pharmacological class in terms of drug expe
Externí odkaz:
https://doaj.org/article/5e9e7b873b3f41d697ffcecec4090914